NCT05892861

Brief Summary

The goal of this clinical trial is to \[learn about cognitive stimulation by multidomain dietary education including the dietary board game via LINE in non-dementic type 2 diabetic adults. The main questions it aims to answer are: \[Question 1: Could multi-domain dietary education as cognitive stimulation improve cognitive function?\] \[Question 2: Could multi-domain dietary education improve dietary control belief ?\] \[Question 3: Could multi-domain dietary education improve health behavior?\] \[Question 4\]: Could multi-domain dietary education improve HbA1C, and lipid profile? Participants of experimental A group will receive a video about lifestyle education 5 minutes weekly for 3 weeks, a dietary board game 10 minutes weekly for 10 weeks, and a 24-hour dietary recall record 2 times weekly for 7 weeks. And participants of the experimental B group receive the usual clinical treatment. Then experimental A and Experimental B groups will cross over 12 weeks later. Researchers will compare the effect of intervention between the experimental A group and the experimental B group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 3, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 14, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 7, 2023

Completed
Last Updated

March 11, 2025

Status Verified

June 1, 2023

Enrollment Period

1.6 years

First QC Date

May 14, 2023

Last Update Submit

March 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The change of cognitive function from baseline at 3 and 6 months

    Saint Louis University Mental State examination, the total score range is 0\~30. Higher scores mean better change.

    12th week & 24 week

Secondary Outcomes (1)

  • The change of dietary control belief from baseline at 3 and 6 months

    12th week and 24th week

Other Outcomes (8)

  • The change of the awareness of complication and health behavior from baseline at 3 and 6 months

    12th week and 24th week

  • The change of HbA1C from baseline at 3 and 6 months

    12th week and 24th week

  • The change of total cholesterol from baseline at 3 and 6 months

    12th week and 24th week

  • +5 more other outcomes

Study Arms (2)

multi domain dietary education as cognitive stimulation

EXPERIMENTAL

video lifestyle education, board game, and 24-hour dietary recall record from 1st week to 10th week as cognitive stimulation.

Behavioral: cognitive stimulation

usual clinical treatment

EXPERIMENTAL

usual treatment in clinic

Other: as usual care

Interventions

video education, board games, and 24-hour dietary recall record

multi domain dietary education as cognitive stimulation

history taking, explain data, and discuss how to control healthy condition

usual clinical treatment

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The onset age of Diabetes Mellitus is more than 20 years old
  • Diagnosis of Diabetes according to past history including type 2 diabetes mellitus or drug history including oral anti-diabetic drugs

You may not qualify if:

  • SLUMS meets the Dementia definition.
  • HbA1C ≥ 10.0%
  • Rejected our study.
  • History of stroke.
  • History of depression.
  • History of psychiatric disease.
  • Visual impairment.
  • Hearing impairment.
  • Can't understand the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yong-Kang Clinic

Kaohsiung City, Taiwan

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Ling-Chun Ou

    National Kaohsiung Normal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 14, 2023

First Posted

June 7, 2023

Study Start

June 3, 2021

Primary Completion

December 31, 2022

Study Completion

March 31, 2023

Last Updated

March 11, 2025

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations